• 1. Synthesis of new fused heterocyclic aromatic hydrocarbons via C–S and C–C bond formation by C–H bond activation in the presence of new Pd(ii) Schiff's base complexes
  Someshwar Pola,Yadagiri Bhongiri,Ramchander Jadhav,Prabhakar Ch,Venkanna G. RSC Adv. 2016 6 88321
• 2. Multicomponent cascade reaction: dual role of copper in the synthesis of 1,2,3-triazole tethered benzimidazo[1,2-a]quinoline and their photophysical studies
  Hunsur Nagendra Nagesh,Amaroju Suresh,Muthyala Nagarjuna Reddy,Narva Suresh,Jayanty Subbalakshmi,Kondapalli Venkata Gowri Chandra Sekhar RSC Adv. 2016 6 15884
• 3. Step-economical synthesis of 3-amido-2-quinolones by dendritic copper powder-mediated one-pot reaction
  Byung Hoon Ahn,Ill Young Lee,Hee Nam Lim Org. Biomol. Chem. 2018 16 7851
• 4. One-pot three-component selective synthesis of isoindolo[2,1-a]quinazoline derivatives via a palladium-catalyzed cascade cyclocondensation/cyclocarbonylation sequence
  Shenghai Guo,Jianhui Zhai,Fang Wang,Xuesen Fan Org. Biomol. Chem. 2017 15 3674
• 5. Silver comes into play: Henry reaction and domino cycloisomerisation sequence catalysed by [Ag(i)(Pc-L)] complexes
  Giorgio Tseberlidis,Monica Dell'Acqua,Daniele Valcarenghi,Emma Gallo,Elisabetta Rossi,Giorgio Abbiati,Alessandro Caselli RSC Adv. 2016 6 97404

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridine carboxaldehydes

Recent Advances in the Application of 2-Bromonicotinaldehyde (CAS: 128071-75-0) in Chemical Biology and Pharmaceutical Research

2-Bromonicotinaldehyde (CAS: 128071-75-0) is a versatile chemical intermediate that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by its bromine substituent and aldehyde functional group, serves as a key building block in the synthesis of various heterocyclic compounds, which are often pivotal in drug discovery and development. Recent studies have highlighted its utility in the construction of nicotinamide derivatives, kinase inhibitors, and other bioactive molecules, making it a valuable tool for medicinal chemists.

One of the most notable applications of 2-Bromonicotinaldehyde is its role in the synthesis of kinase inhibitors. Kinases are critical targets in cancer therapy, and the development of selective inhibitors remains a high priority in oncology research. A 2023 study published in the Journal of Medicinal Chemistry demonstrated the use of 2-Bromonicotinaldehyde as a precursor in the synthesis of novel pyridine-based kinase inhibitors. The researchers employed a palladium-catalyzed cross-coupling reaction to introduce various aryl groups, resulting in compounds with potent inhibitory activity against specific kinase targets. The study underscored the compound's reactivity and versatility in medicinal chemistry applications.

In addition to its role in kinase inhibitor development, 2-Bromonicotinaldehyde has been explored as a key intermediate in the synthesis of nicotinamide derivatives. Nicotinamide-based compounds are of particular interest due to their involvement in cellular metabolism and their potential as therapeutic agents for metabolic disorders. A recent study in Bioorganic & Medicinal Chemistry Letters (2024) detailed the use of 2-Bromonicotinaldehyde in a multi-step synthesis of novel nicotinamide analogs with enhanced bioavailability and metabolic stability. The researchers reported that the bromine substituent facilitated selective functionalization, enabling the creation of diverse analogs for structure-activity relationship studies.

Beyond its applications in drug discovery, 2-Bromonicotinaldehyde has also been investigated in chemical biology for the development of probes and sensors. Its aldehyde group allows for facile conjugation with biomolecules, making it a useful scaffold for designing fluorescent or affinity-based probes. A 2023 publication in Chemical Communications described the use of 2-Bromonicotinaldehyde in the synthesis of a fluorescent probe for detecting reactive oxygen species (ROS) in live cells. The probe exhibited high selectivity and sensitivity, highlighting the compound's potential in diagnostic and imaging applications.

Despite its promising applications, challenges remain in the large-scale synthesis and handling of 2-Bromonicotinaldehyde. Recent advancements in green chemistry have sought to address these issues. A 2024 study in Green Chemistry reported an eco-friendly, catalytic method for the synthesis of 2-Bromonicotinaldehyde, reducing the reliance on hazardous reagents and improving yield. This development is expected to facilitate broader adoption of the compound in industrial and academic settings.

In conclusion, 2-Bromonicotinaldehyde (CAS: 128071-75-0) continues to be a valuable asset in chemical biology and pharmaceutical research. Its versatility as a synthetic intermediate, coupled with recent advancements in its applications and synthesis, positions it as a critical tool for the development of novel therapeutics and probes. Future research is likely to explore its potential in emerging areas such as targeted drug delivery and personalized medicine, further expanding its impact on the field.

• 3430-17-9(2-Bromo-3-methylpyridine)
• 55304-85-3(2,6-dibromopyridine-3-carboxylic acid)
• 87674-18-8(2-bromopyridine-3-carboxamide)
• 35905-85-2(2-bromopyridine-3-carboxylic acid)
• 55304-83-1(2,6-dibromopyridine-3-carbaldehyde)
• 149806-06-4(6-Bromopyridine-3-carboxaldehyde)
• 84199-61-1(1-(2-bromopyridin-3-yl)ethan-1-one)
• 852181-11-4(2,5-Dibromonicotinaldehyde)
• 887571-15-5(2,6-dibromo-3-methyl-pyridine)
• 853179-74-5(2-bromo-6-methylpyridine-3-carbaldehyde)